Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lumir Lab is an Israeli-based biotechnology company and contract research organization (CRO) dedicated to the advancement of cannabinoid-based medicine. Founded by world-renowned cannabinoid researcher Prof. Lumír Hanuš, the company provides high-end analytical services, clinical trial design, and product formulation for the global medical cannabis industry. Lumir Lab operates out of the Hebrew University’s Biotechnology Park, utilizing state-of-the-art laboratory equipment to ensure the safety, efficacy, and standardization of cannabis products. Their business model combines fee-for-service R&D with strategic partnerships to develop novel therapeutic solutions for indications such as chronic pain, women's health, and neurological disorders. The company serves as a bridge between botanical cannabis and pharmaceutical-grade medical treatments.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Lumir Lab.